BioHarvest Sciences Inc.
BHST
$5.65
$0.030.53%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.78% | -111.33% | -57.08% | -86.58% | -11.82% |
| Total Depreciation and Amortization | 48.93% | 37.99% | 25.09% | 9.04% | 17.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 126.11% | 751.09% | 105,225.00% | 315,066.67% | 53.80% |
| Change in Net Operating Assets | -173.51% | -167.09% | 7,275.00% | -149.71% | 345.13% |
| Cash from Operations | 21.57% | 9.25% | 31.57% | -0.62% | 7.78% |
| Capital Expenditure | -92.33% | -89.00% | -107.08% | -6.37% | -17.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -105.36% | -101.80% | -124.59% | -6.37% | -17.36% |
| Total Debt Issued | -75.48% | -19.04% | -21.56% | 53.35% | 76.51% |
| Total Debt Repaid | -249.45% | -40.62% | -25.14% | -20.94% | -1.39% |
| Issuance of Common Stock | 1,075.68% | 1,072.77% | 317.81% | -43.09% | -54.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -49.99% | 29.13% | 10.95% | 47.19% | 66.58% |
| Foreign Exchange rate Adjustments | -157.63% | 723.08% | 808.33% | 277.27% | 368.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -181.93% | 269.57% | 461.20% | 424.64% | 251.99% |